Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Mucosa | 18 | 2009 | 35 | 1.740 |
Why?
|
| Pyloric Antrum | 20 | 1998 | 21 | 1.460 |
Why?
|
| Gastrins | 22 | 1998 | 28 | 1.410 |
Why?
|
| Calcitonin Gene-Related Peptide | 12 | 2004 | 30 | 1.310 |
Why?
|
| Colitis | 4 | 2013 | 53 | 1.270 |
Why?
|
| Gastrointestinal Hemorrhage | 4 | 2009 | 46 | 1.090 |
Why?
|
| Acetylcysteine | 3 | 2013 | 24 | 1.000 |
Why?
|
| Capsaicin | 5 | 2004 | 18 | 0.930 |
Why?
|
| Somatostatin | 11 | 2003 | 25 | 0.910 |
Why?
|
| Neurons, Afferent | 5 | 2004 | 64 | 0.890 |
Why?
|
| Mesalamine | 3 | 2008 | 5 | 0.880 |
Why?
|
| Rats | 30 | 2008 | 1544 | 0.790 |
Why?
|
| Stomach Ulcer | 3 | 2009 | 6 | 0.780 |
Why?
|
| Hamartoma | 3 | 2008 | 13 | 0.740 |
Why?
|
| Transforming Growth Factor alpha | 4 | 2006 | 7 | 0.720 |
Why?
|
| Nitric Oxide | 3 | 2008 | 152 | 0.700 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2008 | 538 | 0.700 |
Why?
|
| Jejunal Neoplasms | 2 | 2008 | 4 | 0.590 |
Why?
|
| Gastrointestinal Stromal Tumors | 2 | 2008 | 11 | 0.590 |
Why?
|
| Gastric Acid | 6 | 2006 | 19 | 0.560 |
Why?
|
| Male | 42 | 2024 | 13017 | 0.550 |
Why?
|
| ErbB Receptors | 2 | 2007 | 96 | 0.530 |
Why?
|
| Free Radical Scavengers | 2 | 2013 | 23 | 0.520 |
Why?
|
| Enema | 2 | 2013 | 7 | 0.500 |
Why?
|
| Colonic Diseases | 3 | 2005 | 10 | 0.500 |
Why?
|
| Animals | 37 | 2013 | 10069 | 0.470 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 164 | 0.470 |
Why?
|
| Stress, Psychological | 3 | 2009 | 209 | 0.470 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 2004 | 22 | 0.460 |
Why?
|
| Stomach | 4 | 2007 | 42 | 0.450 |
Why?
|
| Pouchitis | 1 | 2013 | 1 | 0.450 |
Why?
|
| Duodenal Diseases | 2 | 2008 | 7 | 0.400 |
Why?
|
| Oxidative Stress | 2 | 2013 | 630 | 0.380 |
Why?
|
| Capsule Endoscopy | 2 | 2008 | 7 | 0.370 |
Why?
|
| Stress, Physiological | 2 | 2009 | 90 | 0.360 |
Why?
|
| Acetylcholine | 5 | 1994 | 73 | 0.360 |
Why?
|
| Histamine | 2 | 2007 | 9 | 0.350 |
Why?
|
| Tyrphostins | 2 | 2007 | 4 | 0.330 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2008 | 73 | 0.320 |
Why?
|
| Antioxidants | 2 | 2008 | 222 | 0.320 |
Why?
|
| Liver Failure, Acute | 1 | 2008 | 4 | 0.310 |
Why?
|
| Brunner Glands | 1 | 2008 | 1 | 0.310 |
Why?
|
| Duodenitis | 1 | 2008 | 2 | 0.310 |
Why?
|
| Dinoprostone | 1 | 2008 | 41 | 0.300 |
Why?
|
| Helicobacter pylori | 1 | 2008 | 17 | 0.300 |
Why?
|
| Helicobacter Infections | 1 | 2008 | 16 | 0.300 |
Why?
|
| Clonixin | 1 | 2008 | 1 | 0.300 |
Why?
|
| Veterinary Drugs | 1 | 2008 | 2 | 0.300 |
Why?
|
| Ethanol | 3 | 2004 | 117 | 0.300 |
Why?
|
| Peptic Ulcer | 1 | 2008 | 11 | 0.300 |
Why?
|
| Collagenases | 1 | 2007 | 5 | 0.290 |
Why?
|
| Gastroparesis | 1 | 2007 | 4 | 0.280 |
Why?
|
| Carbachol | 6 | 1994 | 18 | 0.280 |
Why?
|
| Epithelial Cells | 2 | 2007 | 240 | 0.270 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 93 | 0.270 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 270 | 0.250 |
Why?
|
| Indomethacin | 2 | 2003 | 15 | 0.240 |
Why?
|
| Humans | 24 | 2024 | 27143 | 0.220 |
Why?
|
| Intestinal Mucosa | 5 | 2008 | 186 | 0.220 |
Why?
|
| Intestinal Fistula | 1 | 2003 | 3 | 0.220 |
Why?
|
| Jejunal Diseases | 1 | 2003 | 3 | 0.220 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 67 | 0.220 |
Why?
|
| Fistula | 1 | 2003 | 17 | 0.220 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2003 | 24 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2006 | 591 | 0.210 |
Why?
|
| Substance P | 1 | 2003 | 6 | 0.210 |
Why?
|
| Drug Therapy, Combination | 3 | 2008 | 204 | 0.210 |
Why?
|
| Middle Aged | 11 | 2024 | 6907 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 278 | 0.190 |
Why?
|
| Cholinergic Fibers | 2 | 1994 | 5 | 0.180 |
Why?
|
| MicroRNAs | 1 | 2024 | 279 | 0.180 |
Why?
|
| In Vitro Techniques | 7 | 2004 | 240 | 0.170 |
Why?
|
| Duodenum | 1 | 2000 | 15 | 0.170 |
Why?
|
| Inflammation | 1 | 2024 | 605 | 0.170 |
Why?
|
| Rats, Inbred Strains | 10 | 1992 | 63 | 0.160 |
Why?
|
| Eating | 2 | 2007 | 70 | 0.160 |
Why?
|
| Colonoscopy | 3 | 2005 | 58 | 0.160 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2008 | 14 | 0.160 |
Why?
|
| Aged, 80 and over | 3 | 2008 | 1939 | 0.150 |
Why?
|
| Crohn Disease | 2 | 1996 | 26 | 0.140 |
Why?
|
| Peptones | 3 | 1992 | 7 | 0.140 |
Why?
|
| Quinazolines | 2 | 2007 | 31 | 0.140 |
Why?
|
| Genital Diseases, Male | 1 | 1996 | 9 | 0.130 |
Why?
|
| Adaptation, Physiological | 2 | 1994 | 163 | 0.130 |
Why?
|
| Scrotum | 1 | 1996 | 8 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2008 | 1405 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 262 | 0.120 |
Why?
|
| Malabsorption Syndromes | 1 | 1994 | 3 | 0.120 |
Why?
|
| Probability | 2 | 2006 | 75 | 0.120 |
Why?
|
| Receptors, Presynaptic | 1 | 1994 | 1 | 0.120 |
Why?
|
| Receptors, Muscarinic | 1 | 1994 | 9 | 0.120 |
Why?
|
| Random Allocation | 2 | 2006 | 148 | 0.120 |
Why?
|
| Atropine | 4 | 1994 | 47 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 1998 | 627 | 0.110 |
Why?
|
| Reference Values | 2 | 2006 | 199 | 0.110 |
Why?
|
| Calcium | 3 | 1988 | 232 | 0.110 |
Why?
|
| Prostaglandins | 2 | 2004 | 13 | 0.110 |
Why?
|
| Intestines | 1 | 1994 | 117 | 0.110 |
Why?
|
| Neurosecretion | 1 | 1993 | 3 | 0.110 |
Why?
|
| Injections, Intraperitoneal | 2 | 2003 | 34 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 509 | 0.110 |
Why?
|
| Aged | 4 | 2024 | 5223 | 0.100 |
Why?
|
| Endocrine Glands | 1 | 1992 | 3 | 0.100 |
Why?
|
| Parasympathetic Nervous System | 1 | 1992 | 17 | 0.100 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 1991 | 5 | 0.100 |
Why?
|
| Immunohistochemistry | 3 | 2006 | 455 | 0.100 |
Why?
|
| Gastrointestinal Hormones | 1 | 1991 | 1 | 0.100 |
Why?
|
| Peptide PHI | 1 | 1991 | 1 | 0.100 |
Why?
|
| Diet Therapy | 1 | 1991 | 9 | 0.100 |
Why?
|
| Anorexia Nervosa | 1 | 1991 | 11 | 0.100 |
Why?
|
| Biopsy | 2 | 2008 | 201 | 0.090 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1991 | 3 | 0.090 |
Why?
|
| Electric Stimulation | 2 | 2007 | 253 | 0.090 |
Why?
|
| Bucladesine | 5 | 1986 | 11 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1991 | 22 | 0.090 |
Why?
|
| Organ Culture Techniques | 7 | 1988 | 55 | 0.090 |
Why?
|
| Time Factors | 3 | 2007 | 1572 | 0.090 |
Why?
|
| Neurons | 1 | 1992 | 274 | 0.090 |
Why?
|
| Rectal Diseases | 2 | 1996 | 10 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 1994 | 606 | 0.080 |
Why?
|
| Tetrodotoxin | 3 | 1995 | 12 | 0.080 |
Why?
|
| Histamine Antagonists | 1 | 2009 | 4 | 0.080 |
Why?
|
| Proton Pump Inhibitors | 1 | 2009 | 26 | 0.080 |
Why?
|
| Cyclic AMP | 3 | 1988 | 83 | 0.080 |
Why?
|
| Duodenal Ulcer | 2 | 1986 | 5 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2003 | 388 | 0.080 |
Why?
|
| Cyclooxygenase 1 | 1 | 2008 | 9 | 0.080 |
Why?
|
| Vitamin E | 1 | 2008 | 11 | 0.080 |
Why?
|
| Ascorbic Acid | 1 | 2008 | 24 | 0.080 |
Why?
|
| Cyclic N-Oxides | 1 | 2008 | 26 | 0.080 |
Why?
|
| Ileum | 2 | 1992 | 23 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2008 | 66 | 0.080 |
Why?
|
| Critical Illness | 1 | 2009 | 69 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2008 | 39 | 0.080 |
Why?
|
| Intestinal Polyps | 1 | 2008 | 6 | 0.080 |
Why?
|
| Receptors, Cholinergic | 1 | 1988 | 4 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 68 | 0.080 |
Why?
|
| Norepinephrine | 1 | 1988 | 32 | 0.080 |
Why?
|
| Receptors, Adrenergic | 1 | 1988 | 10 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2008 | 100 | 0.080 |
Why?
|
| Prostate-Specific Antigen | 1 | 2008 | 51 | 0.080 |
Why?
|
| Endoscopy, Digestive System | 1 | 2008 | 19 | 0.080 |
Why?
|
| Adenoma, Islet Cell | 1 | 1988 | 1 | 0.080 |
Why?
|
| Vipoma | 1 | 1988 | 2 | 0.080 |
Why?
|
| Horses | 1 | 2008 | 34 | 0.070 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2007 | 2 | 0.070 |
Why?
|
| Famotidine | 1 | 2007 | 3 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2003 | 467 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 23 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 22 | 0.070 |
Why?
|
| Colon | 1 | 2008 | 119 | 0.070 |
Why?
|
| Gastric Emptying | 1 | 2007 | 8 | 0.070 |
Why?
|
| Myoelectric Complex, Migrating | 1 | 2007 | 9 | 0.070 |
Why?
|
| Gastrointestinal Agents | 1 | 2007 | 14 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 86 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 66 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 93 | 0.070 |
Why?
|
| Hormones | 1 | 2007 | 41 | 0.070 |
Why?
|
| Electric Stimulation Therapy | 1 | 2007 | 56 | 0.070 |
Why?
|
| Disease Progression | 1 | 2008 | 458 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 195 | 0.070 |
Why?
|
| Peroxidase | 1 | 2006 | 38 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 143 | 0.070 |
Why?
|
| Female | 8 | 2024 | 14634 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 47 | 0.070 |
Why?
|
| Ranitidine | 1 | 2006 | 9 | 0.070 |
Why?
|
| Histamine H2 Antagonists | 1 | 2006 | 7 | 0.070 |
Why?
|
| Pirenzepine | 3 | 1994 | 8 | 0.070 |
Why?
|
| Theophylline | 2 | 1985 | 6 | 0.060 |
Why?
|
| Colonic Polyps | 1 | 2005 | 17 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 989 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2007 | 307 | 0.060 |
Why?
|
| GABA Antagonists | 1 | 2004 | 4 | 0.060 |
Why?
|
| GABA Agonists | 1 | 2004 | 4 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2006 | 153 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2008 | 468 | 0.060 |
Why?
|
| Kinetics | 3 | 1998 | 538 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2006 | 566 | 0.060 |
Why?
|
| Radioimmunoassay | 4 | 1995 | 45 | 0.060 |
Why?
|
| Peptide Fragments | 3 | 1995 | 200 | 0.060 |
Why?
|
| Carcinogenesis | 1 | 2024 | 79 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2024 | 51 | 0.060 |
Why?
|
| Laparotomy | 1 | 2003 | 29 | 0.060 |
Why?
|
| Risk Factors | 1 | 2009 | 2036 | 0.050 |
Why?
|
| Deuterium | 1 | 1983 | 50 | 0.050 |
Why?
|
| Cytokines | 1 | 2006 | 439 | 0.050 |
Why?
|
| Sympathectomy, Chemical | 1 | 2003 | 1 | 0.050 |
Why?
|
| Immersion | 1 | 2003 | 4 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2024 | 265 | 0.050 |
Why?
|
| Nitroarginine | 1 | 2003 | 4 | 0.050 |
Why?
|
| Gastritis | 1 | 2003 | 3 | 0.050 |
Why?
|
| Nitric Oxide Donors | 1 | 2003 | 11 | 0.050 |
Why?
|
| Immobilization | 1 | 2003 | 15 | 0.050 |
Why?
|
| Intestinal Obstruction | 1 | 1983 | 9 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 56 | 0.050 |
Why?
|
| Intestinal Neoplasms | 1 | 1983 | 15 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2003 | 23 | 0.050 |
Why?
|
| Barium Sulfate | 1 | 1982 | 3 | 0.050 |
Why?
|
| Endometriosis | 1 | 1983 | 19 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 130 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 63 | 0.050 |
Why?
|
| Arginine | 1 | 2003 | 39 | 0.050 |
Why?
|
| Water | 1 | 1983 | 131 | 0.050 |
Why?
|
| Adult | 5 | 2005 | 7498 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2003 | 166 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 1988 | 509 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 247 | 0.050 |
Why?
|
| Stimulation, Chemical | 3 | 1992 | 32 | 0.050 |
Why?
|
| Dogs | 3 | 2007 | 505 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2001 | 28 | 0.050 |
Why?
|
| Tryptophan | 4 | 1984 | 38 | 0.050 |
Why?
|
| Nifedipine | 2 | 1995 | 12 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 377 | 0.050 |
Why?
|
| Calcimycin | 3 | 1988 | 12 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1998 | 46 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1977 | 10 | 0.040 |
Why?
|
| Prostatic Diseases | 1 | 1996 | 3 | 0.030 |
Why?
|
| Urinary Fistula | 1 | 1996 | 2 | 0.030 |
Why?
|
| Urethral Diseases | 1 | 1996 | 6 | 0.030 |
Why?
|
| Egtazic Acid | 2 | 1988 | 10 | 0.030 |
Why?
|
| Verapamil | 2 | 1988 | 9 | 0.030 |
Why?
|
| Abscess | 1 | 1996 | 24 | 0.030 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 2 | 1988 | 3 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1998 | 506 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 1995 | 6 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 1998 | 647 | 0.030 |
Why?
|
| Radiography | 3 | 1988 | 201 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 1985 | 109 | 0.030 |
Why?
|
| Digestive System | 2 | 1991 | 16 | 0.030 |
Why?
|
| Jejunum | 1 | 1992 | 8 | 0.030 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1992 | 5 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 1992 | 7 | 0.020 |
Why?
|
| Perfusion | 1 | 1992 | 43 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 1992 | 10 | 0.020 |
Why?
|
| Muscimol | 1 | 1991 | 8 | 0.020 |
Why?
|
| Autoradiography | 1 | 1991 | 28 | 0.020 |
Why?
|
| Glutamate Decarboxylase | 1 | 1991 | 7 | 0.020 |
Why?
|
| Cholecystokinin | 1 | 1991 | 6 | 0.020 |
Why?
|
| Food, Formulated | 1 | 1991 | 11 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 1992 | 70 | 0.020 |
Why?
|
| Epithelium | 1 | 1991 | 39 | 0.020 |
Why?
|
| Plasma | 1 | 1991 | 32 | 0.020 |
Why?
|
| Pressure | 1 | 1992 | 88 | 0.020 |
Why?
|
| Duodenoscopy | 1 | 1991 | 1 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1992 | 291 | 0.020 |
Why?
|
| Hepatic Encephalopathy | 1 | 1989 | 5 | 0.020 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 1989 | 8 | 0.020 |
Why?
|
| Zollinger-Ellison Syndrome | 2 | 1986 | 2 | 0.020 |
Why?
|
| Sodium Morrhuate | 1 | 1988 | 1 | 0.020 |
Why?
|
| Yohimbine | 1 | 1988 | 4 | 0.020 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1988 | 7 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1988 | 13 | 0.020 |
Why?
|
| Clonidine | 1 | 1988 | 10 | 0.020 |
Why?
|
| Leucine | 1 | 1988 | 20 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 1988 | 31 | 0.020 |
Why?
|
| Satiation | 1 | 2007 | 2 | 0.020 |
Why?
|
| Ghrelin | 1 | 2007 | 7 | 0.020 |
Why?
|
| Peptide Hormones | 1 | 2007 | 4 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2007 | 40 | 0.020 |
Why?
|
| Physostigmine | 1 | 1986 | 2 | 0.020 |
Why?
|
| Postprandial Period | 1 | 2007 | 43 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2007 | 94 | 0.020 |
Why?
|
| Fatty Acids | 1 | 1988 | 201 | 0.020 |
Why?
|
| Bombesin | 2 | 1983 | 8 | 0.020 |
Why?
|
| Leptin | 1 | 2007 | 67 | 0.020 |
Why?
|
| Fasting | 1 | 2007 | 80 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1988 | 156 | 0.020 |
Why?
|
| Receptors, Somatostatin | 1 | 1985 | 8 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 1988 | 975 | 0.020 |
Why?
|
| Insulin | 1 | 2007 | 314 | 0.020 |
Why?
|
| Deuterium Oxide | 1 | 1983 | 3 | 0.010 |
Why?
|
| Bicuculline | 1 | 1983 | 4 | 0.010 |
Why?
|
| Receptors, GABA-A | 1 | 1983 | 18 | 0.010 |
Why?
|
| Portal Vein | 1 | 1982 | 8 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1982 | 27 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1983 | 368 | 0.010 |
Why?
|
| Obesity | 1 | 2007 | 651 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1977 | 109 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 1992 | 37 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1992 | 246 | 0.010 |
Why?
|
| DNA | 1 | 1992 | 365 | 0.010 |
Why?
|
| Proteins | 1 | 1992 | 245 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 1988 | 15 | 0.000 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1988 | 9 | 0.000 |
Why?
|
| Secretin | 1 | 1986 | 2 | 0.000 |
Why?
|
| Gastric Acidity Determination | 1 | 1986 | 4 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1986 | 108 | 0.000 |
Why?
|
| Decision Making | 1 | 1986 | 170 | 0.000 |
Why?
|
| Catheters, Indwelling | 1 | 1982 | 19 | 0.000 |
Why?
|
| Models, Biological | 1 | 1982 | 448 | 0.000 |
Why?
|
| Adolescent | 1 | 1986 | 2991 | 0.000 |
Why?
|